Effect of Metabolic Syndrome on Complex Decongestive Physiotherapy Outcomes in Lymphedema Patients

Investigation of the Effects of Metabolic Syndrome on the Results of Complex Decongestive Physiotherapy in Lymphedema Patients

Sponsors

Lead Sponsor: Gulhane School of Medicine

Source Gulhane School of Medicine
Brief Summary

As a result of our research, investigators could not find any study investigating the effectiveness of complex decongestive physiotherapy (KBF) in lymphedema patients with metabolic syndrome. Therefore, our aim is to compare the effectiveness of KBF in patients with and without metabolic syndrome.

Detailed Description

This study was planned to investigate the effects of metabolic syndrome seen in patients with lymphedema on the results of complex decongestive physiotherapy. Lymphedema is a chronic disease characterized by the accumulation of protein-rich fluid in the interstitial space. Among all the treatment approaches known in the field, Complex Decongestive Physiotherapy (CDT) is accepted as the gold standard in the treatment of lymphedema. CDT is a treatment approach consisting of manual lymph drainage, skin care, compression bandage and exercises. In clinical studies conducted to date, the effectiveness of CDFT in the treatment of lower and upper extremity lymphedema has been clearly demonstrated. Metabolic syndrome is a medical term that describes the combination of various cardiovascular risk factors such as insulin resistance, impaired glucose tolerance or diabetes mellitus, obesity, abdominal fat accumulation, dyslipidemia, hypertension, and coronary artery disease. Obesity, the cardinal component of the metabolic syndrome, is a well-known risk factor for lymphedema, and increased body mass index (BMI) is associated with the frequency and severity of lymphedema. Obesity often accompanies lymphedema due to the effect of lymphedema and the characteristics of patients with lymphedema. Our aim in this study, which was planned in the light of these data, is to examine whether the presence of metabolic syndrome in patients with lymphedema changes the effectiveness of CDT.

Overall Status Recruiting
Start Date 2022-07-15
Completion Date 2022-12-15
Primary Completion Date 2022-09-15
Study Type Observational
Primary Outcome
Measure Time Frame
Limb volume 15.09.2022
Secondary Outcome
Measure Time Frame
Life quality 15.12.2022
Enrollment 40
Condition
Intervention

Intervention Type: Other

Intervention Name: Complex decongestive physiotherapy

Description: CDT is a treatment approach consisting of manual lymph drainage, skin care, compression bandage and exercises.

Eligibility

Sampling Method:

Probability Sample

Criteria:

Inclusion Criteria: - Those between the ages of 18-65, - To be diagnosed with lymphedema in the lower or upper extremities - Volunteering to participate in the study - Getting >24 points from the Standardized Mini mental test Exclusion Criteria: - Having a score of <24 on the Standardized Mini Mental Test - Finding any problem preventing communication

Gender:

All

Minimum Age:

18 Years

Maximum Age:

65 Years

Healthy Volunteers:

No

Overall Contact Contact information is only displayed when the study is recruiting subjects.
Location
Facility: Status: Contact: University of Health Sciences Mustafa Yaşa, Assocc. Prof. 05368584105 [email protected]
Location Countries

Turkey

Verification Date

2022-06-01

Responsible Party

Type: Principal Investigator

Investigator Affiliation: Gulhane School of Medicine

Investigator Full Name: Mustafa Ertuğrul Yaşa

Investigator Title: Assocc. Prof.

Keywords
Has Expanded Access No
Condition Browse
Arm Group

Label: Patients diagnosed with lymphedema with metabolic syndrome

Description: Demographic information of the patients (age, height, weight, occupation, history), comorbid diseases (hypertension, diabetes, cardiac problems, circulatory problems, thyroid dysfunction), operation date, operation type, affected extremity, type of lymphedema will be recorded. In addition to these, mental status, edema and quality of life assessments will also be made. As a treatment, extremity volume and quality of life evaluations will be made before and after the first phase of CDT (manual lymphatic drainage, skin care, compression therapy and exercises) for 3 weeks.

Label: Patients diagnosed with lymphedema without metabolic syndrome

Description: Demographic information of the patients (age, height, weight, occupation, history), comorbid diseases (hypertension, diabetes, cardiac problems, circulatory problems, thyroid dysfunction), operation date, operation type, affected extremity, type of lymphedema will be recorded. In addition to these, mental status, edema and quality of life assessments will also be made. As a treatment, extremity volume and quality of life evaluations will be made before and after the first phase of CDT (manual lymphatic drainage, skin care, compression therapy and exercises) for 3 weeks.

Patient Data No
Study Design Info

Observational Model: Cohort

Time Perspective: Prospective

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact [email protected]. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Research News